Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Salmonella typhi Ty21a strain transfected with a plasmid vector encoding the human vascular endothelial growth factor receptor 2

EU orphan designation number: EU/3/17/1909   
Active ingredient: Salmonella typhi Ty21a strain transfected with a plasmid vector encoding the human vascular endothelial growth factor receptor 2
Indication: Treatment of glioma
Sponsor: Vaximm GmbH
Harrlachweg 2, 68163 Mannheim, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/08/2017 Orphan designation EMA/OD/069/17 (2017)5918 of 23/08/2017
12/11/2018 Change of name and/or address of sponsor